Docoh
Loading...

HRL Hormel Foods

Employees

Data from SEC filings
Employee count
CEO pay ratio
CEO Salary
Median Employee Salary

ESG framework mentions

In last year of SEC filings
Sustainability Accounting Standards Board (SASB)
No mentions
Global Reporting Initiative (GRI)
No mentions
Task Force on Climate-related Financial Disclosures (TCFD)
No mentions
UN Sustainable Development Goals (SDGs)
No mentions

Shareholder alignment

Proxy contests and exempt solicitations in last 3 years
PX14A6G
HRL Hormel Foods Corp.
6 Jan 22
Letter to shareholders
9:34am
Vote support at last AGM



The Company conducted its annual stockholders’ meeting on January 25, 2022.



At the annual meeting, 493,557,074 shares were represented (91.0 percent of the 542,569,949 shares outstanding and entitled to vote). Four items were considered at the meeting and the results of the voting were as follows:



1.Election of Directors: The nominees in the proxy statement were: Prama Bhatt, Gary C. Bhojwani, Terrell K. Crews, Stephen M. Lacy, Elsa A. Murano, Ph.D., Susan K. Nestegard, William A. Newlands, Christopher J. Policinski, Jose Luis Prado, Sally J. Smith, James P. Snee, and Steven A. White. The results were as follows:
DIRECTOR:FORAGAINST
ABSTAIN
BROKER NON-VOTE
Prama Bhatt455,811,0132,960,599382,32334,403,139
Gary C. Bhojwani431,225,29327,529,446399,19634,403,139
Terrell K. Crews450,914,2917,800,278439,36634,403,139
Stephen M. Lacy452,727,9276,003,343422,66534,403,139
Elsa A. Murano, Ph.D.452,786,4736,008,754358,70834,403,139
Susan K. Nestegard452,643,7916,151,092359,05234,403,139
William A. Newlands455,906,7812,849,062398,09234,403,139
Christopher J. Policinski455,167,9503,511,768474,21734,403,139
Jose Luis Prado455,888,7652,869,336395,83434,403,139
Sally J. Smith455,616,2723,124,342413,32134,403,139
James P. Snee447,457,7817,248,6304,447,52434,403,139
Steven A. White449,247,0159,530,120376,80034,403,139





2. Ratification of the appointment of Ernst & Young LLP as the Company’s independent registered public accounting firm for the fiscal year ending October 30, 2022:




For:480,044,981
Against:13,166,961
Abstain:345,132





3. Advisory vote on the compensation of the Company’s Named Executive Officers, as disclosed in the Company’s 2022 annual meeting proxy statement (as filed with the Securities and Exchange Commission on December 15, 2021):




For:446,806,572
Against:11,508,484
Abstain:838,879
Broker Non-Vote:34,403,139








2




4. Stockholder proposal requesting a report on external public health costs of antimicrobial resistance:




For:31,543,629
Against:425,133,094
Abstain:2,477,212
Broker Non-Vote:34,403,139


3